Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

410 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunotherapy for ovarian cancer: what's next?
Kandalaft LE, Powell DJ Jr, Singh N, Coukos G. Kandalaft LE, et al. Among authors: coukos g. J Clin Oncol. 2011 Mar 1;29(7):925-33. doi: 10.1200/JCO.2009.27.2369. Epub 2010 Nov 15. J Clin Oncol. 2011. PMID: 21079136 Free PMC article. Review.
Cancer immunotherapy: hype or ripe? [corrected].
Romero P, Coukos G. Romero P, et al. Among authors: coukos g. Eur J Immunol. 2014 Feb;44(2):318-20. doi: 10.1002/eji.201444472. Eur J Immunol. 2014. PMID: 24510499 Free article. No abstract available.
Personalized approaches to active immunotherapy in cancer.
Ophir E, Bobisse S, Coukos G, Harari A, Kandalaft LE. Ophir E, et al. Among authors: coukos g. Biochim Biophys Acta. 2016 Jan;1865(1):72-82. doi: 10.1016/j.bbcan.2015.07.004. Epub 2015 Aug 1. Biochim Biophys Acta. 2016. PMID: 26241169 Review.
Opportunities in immunotherapy of ovarian cancer.
Coukos G, Tanyi J, Kandalaft LE. Coukos G, et al. Ann Oncol. 2016 Apr;27 Suppl 1(Suppl 1):i11-i15. doi: 10.1093/annonc/mdw084. Ann Oncol. 2016. PMID: 27141063 Free PMC article. Review.
A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study.
Monk BJ, Brady MF, Aghajanian C, Lankes HA, Rizack T, Leach J, Fowler JM, Higgins R, Hanjani P, Morgan M, Edwards R, Bradley W, Kolevska T, Foukas P, Swisher EM, Anderson KS, Gottardo R, Bryan JK, Newkirk M, Manjarrez KL, Mannel RS, Hershberg RM, Coukos G. Monk BJ, et al. Among authors: coukos g. Ann Oncol. 2017 May 1;28(5):996-1004. doi: 10.1093/annonc/mdx049. Ann Oncol. 2017. PMID: 28453702 Free PMC article. Clinical Trial.
Cancer immunotherapy full speed ahead.
Melero I, Navarro B, Teijeira A, Coukos G. Melero I, et al. Among authors: coukos g. Ann Oncol. 2017 Dec 1;28(suppl_12):xii1-xii2. doi: 10.1093/annonc/mdx739. Ann Oncol. 2017. PMID: 29253117 Free article. No abstract available.
410 results